Study: Medical Cannabis Effective Against Anxiety and Depression for Autism Patients

Ganjapreneur
By Graham AbbottOct 5, 2026, 10:37 am73 pts
Minnesota patients with autism reported reduced presence and severity of anxiety and depression symptoms after starting with the medical cannabis program, according to a study published last week by the Minnesota Office of Cannabis Management (OCM). The study utilized data collected from 1,811 Minnesota adult…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Illinois Marijuana Retailers Sold to Minors in Just 6 of 1,452 State Compliance Checks 78

New York Sets November 5 Opening for Marijuana Nursery Licenses, With Applications Capped at 50 77

Study: Medical Cannabis Effective Against Anxiety and Depression for Autism Patients 73

USDA Report Finds U.S. Hemp Fiber Production More Than Tripled Since 2022, Reaching 65 Million Pounds 72

Vanquish Medical Brings Craft Cannabis to Canadian Patients 67

Study: Pancreatic Cancer Patients Taking at Least 10 MG of THC Daily Saw Broader Symptom Improvements Than Those Taking Less 54

Massachusetts Governor Urges Voters To Keep Marijuana Sales Legal By Rejecting Prohibitionist Ballot Measure 41

Minnesota Has Issued Nearly 400 Marijuana Business Licenses, With 223 Adult-Use Retail Sites Now Licensed 18

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.